-
Something wrong with this record ?
Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners
V. Křen
Language English Country Switzerland
Document type Journal Article, Review
Grant support
21-01799S
Grantová Agentura České Republiky
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
PubMed Central
from 2007
Europe PubMed Central
from 2007
ProQuest Central
from 2000-03-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2007-01-01
Health & Medicine (ProQuest)
from 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
PubMed
34360650
DOI
10.3390/ijms22157885
Knihovny.cz E-resources
- MeSH
- Anti-Infective Agents chemistry pharmacology MeSH
- Antioxidants chemistry pharmacology MeSH
- Antineoplastic Agents, Phytogenic chemistry pharmacology MeSH
- Humans MeSH
- Silybin chemistry pharmacology MeSH
- Stereoisomerism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
This review focuses on the specific biological effects of optically pure silymarin flavo-nolignans, mainly silybins A and B, isosilybins A and B, silychristins A and B, and their 2,3-dehydro derivatives. The chirality of these flavonolignans is also discussed in terms of their analysis, preparative separation and chemical reactions. We demonstrated the specific activities of the respective diastereomers of flavonolignans and also the enantiomers of their 2,3-dehydro derivatives in the 3D anisotropic systems typically represented by biological systems. In vivo, silymarin flavonolignans do not act as redox antioxidants, but they play a role as specific ligands of biological targets, according to the "lock-and-key" concept. Estrogenic, antidiabetic, anticancer, antiviral, and antiparasitic effects have been demonstrated in optically pure flavonolignans. Potential application of pure flavonolignans has also been shown in cardiovascular and neurological diseases. Inhibition of drug-metabolizing enzymes and modulation of multidrug resistance activity by these compounds are discussed in detail. The future of "silymarin applications" lies in the use of optically pure components that can be applied directly or used as valuable lead structures, and in the exploration of their true molecular effects.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21025307
- 003
- CZ-PrNML
- 005
- 20211026133933.0
- 007
- ta
- 008
- 211013s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms22157885 $2 doi
- 035 __
- $a (PubMed)34360650
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Křen, Vladimír $u Laboratory of Biotransformation, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic
- 245 10
- $a Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners / $c V. Křen
- 520 9_
- $a This review focuses on the specific biological effects of optically pure silymarin flavo-nolignans, mainly silybins A and B, isosilybins A and B, silychristins A and B, and their 2,3-dehydro derivatives. The chirality of these flavonolignans is also discussed in terms of their analysis, preparative separation and chemical reactions. We demonstrated the specific activities of the respective diastereomers of flavonolignans and also the enantiomers of their 2,3-dehydro derivatives in the 3D anisotropic systems typically represented by biological systems. In vivo, silymarin flavonolignans do not act as redox antioxidants, but they play a role as specific ligands of biological targets, according to the "lock-and-key" concept. Estrogenic, antidiabetic, anticancer, antiviral, and antiparasitic effects have been demonstrated in optically pure flavonolignans. Potential application of pure flavonolignans has also been shown in cardiovascular and neurological diseases. Inhibition of drug-metabolizing enzymes and modulation of multidrug resistance activity by these compounds are discussed in detail. The future of "silymarin applications" lies in the use of optically pure components that can be applied directly or used as valuable lead structures, and in the exploration of their true molecular effects.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiinfekční látky $x chemie $x farmakologie $7 D000890
- 650 _2
- $a fytogenní protinádorové látky $x chemie $x farmakologie $7 D000972
- 650 _2
- $a antioxidancia $x chemie $x farmakologie $7 D000975
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a silibinin $x chemie $x farmakologie $7 D000077385
- 650 _2
- $a stereoizomerie $7 D013237
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 15 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34360650 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133939 $b ABA008
- 999 __
- $a ok $b bmc $g 1714385 $s 1145814
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 22 $c 15 $e 20210723 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a 21-01799S $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20211013